(Q35977304)

11 August 2017

Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody (English)

1 reference

11 August 2017

1 reference

1 reference

1 reference

Hird V

1

1 reference

11 August 2017

Maraveyas A

2

1 reference

11 August 2017

Snook D

3

1 reference

11 August 2017

Dhokia B

4

1 reference

11 August 2017

Soutter WP

5

1 reference

11 August 2017

Meares C

6

1 reference

11 August 2017

Stewart JS

7

1 reference

11 August 2017

Mason P

8

1 reference

11 August 2017

Lambert HE

9

1 reference

11 August 2017

Epenetos AA

10

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 August 1993

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

68

1 reference

11 August 2017

403-406

1 reference

11 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1993.349

11 August 2017

0 references

cites work

Human monoclonal antibodies produced by primary in vitro immunization of peripheral blood lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968585

Reshaping human antibodies for therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968585

Cloning of partial cDNA encoding differentiation and tumor-associated mucin glycoproteins expressed by human mammary epithelium

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968585

Mouse/human chimeric monoclonal antibody in man: kinetics and immune response

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968585

Macrocyclic chelates of radiometals for diagnosis and therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968585

Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG))

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968585

Patients receiving murine monoclonal antibody therapy for malignancy develop T cells that proliferate in vitro in response to these antibodies as antigens

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968585

Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968585

Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968585

Estimates of radiation absorbed dose for intraperitoneally administered iodine-131 radiolabeled B72.3 monoclonal antibody in patients with peritoneal carcinomatoses.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968585

Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers

24 September 2018

1 reference

12 December 2020

Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy

1 reference

12 December 2020

Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody

1 reference

12 December 2020

Antibody-guided irradiation of malignant lesions: three cases illustrating a new method of treatment. A report from the Hammersmith Oncology Group and the Imperial Cancer Research Fund

1 reference

12 December 2020

Radioimmunodetection in patients with suspected ovarian cancer

1 reference

12 December 2020

Development of anti-idiotypic antibodies against tumour antigens and autoantigens in ovarian cancer patients treated intraperitoneally with mouse monoclonal antibodies

1 reference

12 December 2020

Intraperitoneal radioimmunotherapy for ovarian cancer: pharmacokinetics, toxicity, and efficacy of I-131 labeled monoclonal antibodies

1 reference

12 December 2020

Intraperitoneal yttrium-90-labeled monoclonal antibody in ovarian cancer

1 reference

12 December 2020

Coordinate elevation of serum markers in ovarian cancer but not in benign disease

1 reference

12 December 2020

TARGETING OF IODINE-123-LABELLED TUMOUR-ASSOCIATED MONOCLONAL ANTIBODIES TO OVARIAN, BREAST, AND GASTROINTESTINAL TUMOURS

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1993.349

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference

11 August 2017

1 reference